Back to mobile site

Cyclacel Pharma (CYCC) Tops Q3 EPS by 18c

November 10, 2021 4:47 PM EST

Cyclacel Pharma (NASDAQ: CYCC) reported Q3 EPS of ($0.47), $0.18 better than the analyst estimate of ($0.65).

For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings